|
CABA Cabaletta Bio Inc 1759138 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-43,515,000.00 |
| Balance Sheet |
|
Current Assets
|
$122,316,000.00 |
|
Assets
|
$148,146,000.00 |
|
Current Liabilities
|
$41,507,000.00 |
|
Liabilities
|
$44,841,000.00 |
|
Equity
|
$103,305,000.00 |
|
Shares Out
|
100479323.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-42,561,000.00 |
|
Investing Cash Flow
|
$50,960,000.00 |
| Market Analysis |
Market Cap
|
$273,303,758.56 |
|
Price
|
$2.66 |
|
BVPS
|
1.03 |
|
PB
|
2.64 |
|
EPS
|
-0.39 |
|
FCF
|
$-42,561,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:26 |
|
| Apr |
May |
Jun |
| 2026-03-23 |
-0.40 |
|
|
2026-05-14 |
-0.39 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.73 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.44 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CABA documents filed with the SEC.
CABA Filings
Clear
